The companies announced the partnership at the Advanced Technologies & Treatments for Diabetes (ATTD) conference in Barcelona, Spain. It seeks to develop and commercialize the integrated AID system with an initial focus centered around European countries.
According to a news release, the partnership aims to design the integrated AID system to connect Abbott’s FreeStyle Libre 3 sensor — touted as the world’s smallest and most accurate continuous glucose monitoring sensor (CGM) with readings every minute — to CamDiab’s CamAPS FX mobile app, which connects with Ypsomed’s mylife YpsoPump.
Get the full story at our sister site, Drug Delivery Business News.